生物标志物在心肌纤维化中的作用。

Ding Yuejia, Wang Yuan, Zhang Wanqin, Jia Qiujin, Wang Xiaoling, Li Yanyang, Lv Shichao, Zhang Junping

1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

3Qian'an Hospital of Traditional Chinese Medicine, Qian'an 064400, China.

Aging Dis. 2020 Oct 1;11(5):1157-1174. doi: 10.14336/AD.2020.0604. eCollection 2020 Oct.

Myocardial fibrosis is observed in various cardiovascular diseases and plays a key role in the impairment of cardiac function. Endomyocardial biopsy, as the gold standard for the diagnosis of myocardial fibrosis, has limitations in terms of clinical application. Therefore, biomarkers have been recommended for noninvasive assessment of myocardial fibrosis. This review discusses the role of biomarkers in myocardial fibrosis from the perspective of collagen.

心肌纤维化在多种心血管疾病中均有观察到，并且在心脏功能损害中起关键作用。心内膜心肌活检作为诊断心肌纤维化的金标准，在临床应用方面存在局限性。因此，推荐使用生物标志物对心肌纤维化进行无创评估。本综述从胶原蛋白的角度探讨了生物标志物在心肌纤维化中的作用。

相似文献

Roles of Biomarkers in Myocardial Fibrosis.

Aging Dis. 2020 Oct 1;11(5):1157-1174. doi: 10.14336/AD.2020.0604. eCollection 2020 Oct.

Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

J Am Coll Cardiol. 2015 Jun 9;65(22):2449-56. doi: 10.1016/j.jacc.2015.04.026.

Influence of acute or chronic rejection on myocardial collagen density in serial endomyocardial biopsy specimens from cardiac allografts.

J Heart Lung Transplant. 1996 Aug;15(8):796-803.

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Circulation. 2010 Jul 13;122(2):138-44. doi: 10.1161/CIRCULATIONAHA.109.930636. Epub 2010 Jun 28.

Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.

Heart Fail Rev. 2015 Nov;20(6):731-49. doi: 10.1007/s10741-015-9509-4.

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.

Circulation. 2004 Sep 7;110(10):1263-8. doi: 10.1161/01.CIR.0000140973.60992.9A. Epub 2004 Aug 16.

Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels.

Anadolu Kardiyol Derg. 2011 Feb;11(1):71-6. doi: 10.5152/akd.2011.013. Epub 2011 Jan 11.

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):210-6. doi: 10.1093/ehjci/jeu183. Epub 2014 Sep 22.

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.

J Am Coll Cardiol. 2016 Jan 26;67(3):251-60. doi: 10.1016/j.jacc.2015.10.063.

Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.

Eur J Heart Fail. 2015 Apr;17(4):385-92. doi: 10.1002/ejhf.246. Epub 2015 Feb 11.

引用本文的文献

Nanomedicine for Diagnosis and Treatment of Cardiac Fibrosis.

Int J Nanomedicine. 2025 Aug 7;20:9723-9746. doi: 10.2147/IJN.S520967. eCollection 2025.

Interactions between atrial fibrosis and inflammation in atrial fibrillation.

Front Cardiovasc Med. 2025 Jul 10;12:1578148. doi: 10.3389/fcvm.2025.1578148. eCollection 2025.

Salt sensitivity and myocardial fibrosis: unraveling the silent cardiovascular remodeling.

Front Pharmacol. 2025 Jun 13;16:1626492. doi: 10.3389/fphar.2025.1626492. eCollection 2025.

Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study.

Diagnostics (Basel). 2025 Apr 30;15(9):1143. doi: 10.3390/diagnostics15091143.

Evaluation of galectin-3 and titin in cats with a sarcomeric gene mutation associated with echocardiography.

Vet World. 2024 Oct;17(10):2407-2416. doi: 10.14202/vetworld.2024.2407-2416. Epub 2024 Oct 31.

Research Progress of Fibroblasts in Human Diseases.

Biomolecules. 2024 Nov 20;14(11):1478. doi: 10.3390/biom14111478.

Exploring in vivo and in vitro models for heart failure with biomarker insights: a review.

Egypt Heart J. 2024 Oct 21;76(1):141. doi: 10.1186/s43044-024-00568-1.

Preventive and treatment efficiency of dendrosomal nano-curcumin against ISO-induced cardiac fibrosis in mouse model.

PLoS One. 2024 Oct 10;19(10):e0311817. doi: 10.1371/journal.pone.0311817. eCollection 2024.

Transcriptional response of the heart to vagus nerve stimulation.

Physiol Genomics. 2024 Feb 1;56(2):167-178. doi: 10.6084/m9.figshare.24449590. Epub 2023 Dec 4.

Unraveling the Cardiac Matrix: From Diabetes to Heart Failure, Exploring Pathways and Potential Medications.

Biomedicines. 2024 Jun 13;12(6):1314. doi: 10.3390/biomedicines12061314.

本文引用的文献

GHSR deficiency exacerbates cardiac fibrosis: role in macrophage inflammasome activation and myofibroblast differentiation.

Cardiovasc Res. 2020 Nov 1;116(13):2091-2102. doi: 10.1093/cvr/cvz318.

Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?

Mol Cell Biochem. 2020 Jan;464(1-2):143-152. doi: 10.1007/s11010-019-03656-y. Epub 2019 Nov 29.

Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway.

J Ethnopharmacol. 2020 Mar 1;249:112404. doi: 10.1016/j.jep.2019.112404. Epub 2019 Nov 15.

Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis.

Free Radic Biol Med. 2020 Jan;146:198-210. doi: 10.1016/j.freeradbiomed.2019.10.416. Epub 2019 Nov 2.

Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Cardiovasc Pathol. 2019 Nov-Dec;43:107150. doi: 10.1016/j.carpath.2019.107150. Epub 2019 Aug 28.

MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.

Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8087-8094. doi: 10.26355/eurrev_201909_19026.

Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K/Akt signaling pathway via PIK3CA.

Gene. 2019 Oct 5;715:143995. doi: 10.1016/j.gene.2019.143995. Epub 2019 Jul 20.

Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF.

Front Physiol. 2019 Jun 4;10:690. doi: 10.3389/fphys.2019.00690. eCollection 2019.

Relations between markers of cardiac remodelling and left ventricular collagen in an isoproterenol-induced heart damage model.

J Physiol Pharmacol. 2019 Feb;70(1). doi: 10.26402/jpp.2019.1.08. Epub 2019 Apr 20.

The role and mechanism of transforming growth factor beta 3 in human myocardial infarction-induced myocardial fibrosis.

J Cell Mol Med. 2019 Jun;23(6):4229-4243. doi: 10.1111/jcmm.14313. Epub 2019 Apr 14.

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

Ding Yuejia, Wang Yuan, Zhang Wanqin, Jia Qiujin, Wang Xiaoling, Li Yanyang, Lv Shichao, Zhang Junping

1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

3Qian'an Hospital of Traditional Chinese Medicine, Qian'an 064400, China.

Aging Dis. 2020 Oct 1;11(5):1157-1174. doi: 10.14336/AD.2020.0604. eCollection 2020 Oct.

相似文献

Roles of Biomarkers in Myocardial Fibrosis.

Aging Dis. 2020 Oct 1;11(5):1157-1174. doi: 10.14336/AD.2020.0604. eCollection 2020 Oct.

Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

J Am Coll Cardiol. 2015 Jun 9;65(22):2449-56. doi: 10.1016/j.jacc.2015.04.026.

Influence of acute or chronic rejection on myocardial collagen density in serial endomyocardial biopsy specimens from cardiac allografts.

J Heart Lung Transplant. 1996 Aug;15(8):796-803.

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Circulation. 2010 Jul 13;122(2):138-44. doi: 10.1161/CIRCULATIONAHA.109.930636. Epub 2010 Jun 28.

Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.

Heart Fail Rev. 2015 Nov;20(6):731-49. doi: 10.1007/s10741-015-9509-4.

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.

Circulation. 2004 Sep 7;110(10):1263-8. doi: 10.1161/01.CIR.0000140973.60992.9A. Epub 2004 Aug 16.

Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels.

Anadolu Kardiyol Derg. 2011 Feb;11(1):71-6. doi: 10.5152/akd.2011.013. Epub 2011 Jan 11.

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):210-6. doi: 10.1093/ehjci/jeu183. Epub 2014 Sep 22.

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.

J Am Coll Cardiol. 2016 Jan 26;67(3):251-60. doi: 10.1016/j.jacc.2015.10.063.

Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.

Eur J Heart Fail. 2015 Apr;17(4):385-92. doi: 10.1002/ejhf.246. Epub 2015 Feb 11.

引用本文的文献

Nanomedicine for Diagnosis and Treatment of Cardiac Fibrosis.

Int J Nanomedicine. 2025 Aug 7;20:9723-9746. doi: 10.2147/IJN.S520967. eCollection 2025.

Interactions between atrial fibrosis and inflammation in atrial fibrillation.

Front Cardiovasc Med. 2025 Jul 10;12:1578148. doi: 10.3389/fcvm.2025.1578148. eCollection 2025.

Salt sensitivity and myocardial fibrosis: unraveling the silent cardiovascular remodeling.

Front Pharmacol. 2025 Jun 13;16:1626492. doi: 10.3389/fphar.2025.1626492. eCollection 2025.

Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study.

Diagnostics (Basel). 2025 Apr 30;15(9):1143. doi: 10.3390/diagnostics15091143.

Evaluation of galectin-3 and titin in cats with a sarcomeric gene mutation associated with echocardiography.

Vet World. 2024 Oct;17(10):2407-2416. doi: 10.14202/vetworld.2024.2407-2416. Epub 2024 Oct 31.

Research Progress of Fibroblasts in Human Diseases.

Biomolecules. 2024 Nov 20;14(11):1478. doi: 10.3390/biom14111478.

Exploring in vivo and in vitro models for heart failure with biomarker insights: a review.

Egypt Heart J. 2024 Oct 21;76(1):141. doi: 10.1186/s43044-024-00568-1.

Preventive and treatment efficiency of dendrosomal nano-curcumin against ISO-induced cardiac fibrosis in mouse model.

PLoS One. 2024 Oct 10;19(10):e0311817. doi: 10.1371/journal.pone.0311817. eCollection 2024.

Transcriptional response of the heart to vagus nerve stimulation.

Physiol Genomics. 2024 Feb 1;56(2):167-178. doi: 10.6084/m9.figshare.24449590. Epub 2023 Dec 4.

Unraveling the Cardiac Matrix: From Diabetes to Heart Failure, Exploring Pathways and Potential Medications.

Biomedicines. 2024 Jun 13;12(6):1314. doi: 10.3390/biomedicines12061314.

本文引用的文献

GHSR deficiency exacerbates cardiac fibrosis: role in macrophage inflammasome activation and myofibroblast differentiation.

Cardiovasc Res. 2020 Nov 1;116(13):2091-2102. doi: 10.1093/cvr/cvz318.

Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?

Mol Cell Biochem. 2020 Jan;464(1-2):143-152. doi: 10.1007/s11010-019-03656-y. Epub 2019 Nov 29.

Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway.

J Ethnopharmacol. 2020 Mar 1;249:112404. doi: 10.1016/j.jep.2019.112404. Epub 2019 Nov 15.

Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis.

Free Radic Biol Med. 2020 Jan;146:198-210. doi: 10.1016/j.freeradbiomed.2019.10.416. Epub 2019 Nov 2.

Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Cardiovasc Pathol. 2019 Nov-Dec;43:107150. doi: 10.1016/j.carpath.2019.107150. Epub 2019 Aug 28.

MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.

Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8087-8094. doi: 10.26355/eurrev_201909_19026.

Up-regulation of microRNA-203 inhibits myocardial fibrosis and oxidative stress in mice with diabetic cardiomyopathy through the inhibition of PI3K/Akt signaling pathway via PIK3CA.

Gene. 2019 Oct 5;715:143995. doi: 10.1016/j.gene.2019.143995. Epub 2019 Jul 20.

Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF.

Front Physiol. 2019 Jun 4;10:690. doi: 10.3389/fphys.2019.00690. eCollection 2019.

Relations between markers of cardiac remodelling and left ventricular collagen in an isoproterenol-induced heart damage model.

J Physiol Pharmacol. 2019 Feb;70(1). doi: 10.26402/jpp.2019.1.08. Epub 2019 Apr 20.

The role and mechanism of transforming growth factor beta 3 in human myocardial infarction-induced myocardial fibrosis.

J Cell Mol Med. 2019 Jun;23(6):4229-4243. doi: 10.1111/jcmm.14313. Epub 2019 Apr 14.

Roles of Biomarkers in Myocardial Fibrosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

生物标志物在心肌纤维化中的作用。

Roles of Biomarkers in Myocardial Fibrosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献